QQ客服 官方微博 反馈留言

浏览/检索结果: 共8条，第1-8条 帮助 限定条件 专题：中国医学科学院 北京协和医学院    第一署名单位    第一作者单位    通讯作者单位     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Eribulin mesilate versus vinorelbine in women with locally recurrent or metastatic breast cancer: A randomised clinical trial 期刊论文 2019, 卷号: 112, 页码: 57-65 作者:  Yuan, Peng;  Hu, Xichun;  Sun, Tao;  Li, Wei;  Zhang, Qingyuan 收藏  |  浏览/下载：20/0  |  提交时间：2020/01/03 Progression-free survival  Tolerability  Locally recurrent or metastatic breast cancer  Eribulin   Utidelone plus capecitabine versus capecitabine alone for heavily pretreated metastatic breast cancer refractory to anthracyclines and taxanes: a multicentre, open-label, superiority, phase 3, randomised controlled trial 期刊论文 2017, 卷号: 18, 期号: 3, 页码: 371-383 作者:  Zhang, Pin;  Sun, Tao;  Zhang, Qingyuan;  Yuan, Zhongyu;  Jiang, Zefei 收藏  |  浏览/下载：12/0  |  提交时间：2020/01/04 Outcomes of re-treatment with first-line trastuzumab plus taxane in patients (pts) with metastatic breast cancer (mBC) who relapsed after (neo)adjuvant trastuzumab: A prospective multicenter study. 期刊论文 2016, 卷号: 34, 期号: 15 作者:  Xu, Binghe;  Hu, Xi-Chun;  Zheng, Hong;  Wang, Xiaojia;  Zhang, Qingyuan 收藏  |  浏览/下载：6/0  |  提交时间：2020/01/04 Outcomes of re-treatment with first-line Trastuzumab plus a taxane in HER2 positive metastatic breast cancer patients after (neo)adjuvant Trastuzumab: A prospective multicenter study 期刊论文 2016, 卷号: 7, 期号: 31, 页码: 50643-50655 作者:  Xu, Binghe;  Hu, Xichun;  Zheng, Hong;  Wang, Xiaojia;  Zhang, Qingyuan 收藏  |  浏览/下载：3/0  |  提交时间：2020/01/04 trastuzumab  human epidermal growth factor receptor 2 (HER2)  metastatic breast cancer  (Neo)adjuvant trastuzumab  relapse  re-treatment   Randomized phase III trial of utidelone, a genetically engineered epothilone analog, in combination with capecitabine versus capecitabine alone for metastatic breast cancer patients with previous taxane and anthracycline treatment. 期刊论文 2016, 卷号: 34, 期号: 15 作者:  Xu, Binghe;  Sun, Tao;  Zhang, Qingyuan;  Yuan, Zhongyu;  Zhang, Pin 收藏  |  浏览/下载：4/0  |  提交时间：2020/01/04 Randomized phase III trial of utidelone, a genetically engineered epothilone analog, in combination with capecitabine versus capecitabine alone for metastatic breast cancer patients with previous taxane and anthracycline treatment. 会议论文 JOURNAL OF CLINICAL ONCOLOGY, 2016-05-20 作者:  Xu, Binghe;  Sun, Tao;  Zhang, Qingyuan;  Yuan, Zhongyu;  Zhang, Pin 收藏  |  浏览/下载：4/0  |  提交时间：2020/01/04 Outcomes of re-treatment with first-line trastuzumab plus taxane in patients (pts) with metastatic breast cancer (mBC) who relapsed after (neo)adjuvant trastuzumab: A prospective multicenter study. 会议论文 JOURNAL OF CLINICAL ONCOLOGY, 2016-05-20 作者:  Xu, Binghe;  Hu, Xi-Chun;  Zheng, Hong;  Wang, Xiaojia;  Zhang, Qingyuan 收藏  |  浏览/下载：6/0  |  提交时间：2020/01/04 National consensus in China on diagnosis and treatment of patients with advanced breast cancer 期刊论文 2015, 卷号: 4, 期号: 5, 页码: 557-573 作者:  Xu, Binghe;  Hu, Xichun;  Jiang, Zefei;  Li, Huiping;  Chen, Jiayi 收藏  |  浏览/下载：2/0  |  提交时间：2020/01/04 Advanced breast cancer (ABC)  consensus  national  China